Data Animal Data In pregnant rats given twice weekly subcutaneous doses of 0.02, 0.1, and 0.5 mg/kg tirzepatide (0.03-, 0.07-, and 0.5-fold the MRHD of 15 mg once weekly based on AUC) during organogenesis, increased incidences of external, visceral, and skeletal malformations, increased incidences of visceral and skeletal developmental variations, and decreased fetal weights coincided with pharmacologically-mediated reductions in maternal body weights and food consumption at 0.5 mg/kg
Before each draw, community protocols describe checking the solution
GLP-1 agonists improve insulin sensitivity
For example, a 2mg study dose can be shown in the calculator as exactly 0.2mL or 20 units when using a 10mg vial with 1mL reconstitution
Once the fat cells are destroyed, they cannot regenerate
Storage Store at -20C, protect from light